跳至主要内容
临床试验/IRCT20091027002639N21
IRCT20091027002639N21招募中2 期

Clinical trial of evaluation of effectiveness and clinical side effects of levetiracetam and topiramate in control of seizures of oral prednisolone refractory infantile spasms

Yazd University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 months 至 1 year(—)
性别
All

入选标准

  • Age range of 2 months-1 year
  • Having infantile spasms based on definition of the International League Against Epilepsy
  • Resistance of their seizure to treatment of 2 mg/kg/day prednisolone for two months
  • Not used of other antiepileptic drugs

排除标准

  • Discontinuation of levetiracetam and topiramate usage for more than one week
  • Allergy to levetiracetam and topiramate
  • Irregular drugs usage
  • Not returning for follow up

研究者

发起方
Yazd University of Medical Sciences

相似试验